Real-world multicenter study of T-DXd treatment in Chinese patients with metastatic breast cancer

被引:0
|
作者
Wang, Biyun [1 ]
Li, Yumeng [1 ]
Zhao, Yannan [1 ]
Sang, Die [2 ]
Yuan, Peng [3 ]
Zhao, Yanxia [4 ]
Lv, Zheng [4 ]
Xie, Ning [5 ]
Li, Nanling [6 ]
Li, Juanjuan [7 ]
Wang, Fang [8 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Beijing Zhongke Sanhuan Hitech Co Ltd, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Tumor Hosp, Beijing, Peoples R China
[4] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan, Peoples R China
[5] Hunan Canc Hosp, Changsha, Hunan, Peoples R China
[6] Xijing Hosp, Xian, Peoples R China
[7] Wuhan Univ, Renmin Hosp, Wuhan, Peoples R China
[8] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
来源
LANCET REGIONAL HEALTH-WESTERN PACIFIC | 2025年 / 55卷
关键词
breast cancer; real-world effectiveness; trastuzumab deruxtecan; systemic therapy;
D O I
10.1016/j.lanwpc.2024.101416
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Real-world effectiveness of eribulin in heavily pretreated patients with metastatic breast cancer in China: a multicenter retrospective study
    Zhao, Yannan
    Xie, Ning
    Li, Wei
    Chen, Wenyan
    Lv, Zheng
    Zheng, Yabing
    Sun, Tao
    Liu, Jieqiong
    Zhang, Jian
    Hu, Shihui
    Wang, Yajun
    Gong, Chengcheng
    Li, Yi
    Xie, Yizhao
    Ge, Rui
    Xu, Fei
    Wang, Biyun
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [2] Efficacy and safety of lapatinib in Chinese breast cancer patients: a real-world study
    Ye, Xuan
    Luo, Xin
    Du, Qiong
    Li, Huan
    Liu, Hong-Yue
    Yu, Bo
    Zhai, Qing
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (05)
  • [3] Real-world evidence of Trastuzumab Deruxtecan (T-DXd) Efficacy in HER2-expressing gynecological malignancies
    Andrikopoulou, Angeliki
    Zagouri, Flora
    Goula, Kallirroi
    Haidopoulos, Dimitrios
    Thomakos, Nikolaos
    Svarna, Anna
    Dimopoulos, Meletios-Athanasios
    Liontos, Michalis
    BMC CANCER, 2024, 24 (01)
  • [4] Neutropenic complications in Chinese patients with breast cancer in a real-world setting
    Ye, Xuan
    Zhai, Qing
    Wang, Zhe-Yuan
    Du, Qiong
    Zhu, Bin
    Yu, Bo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (01): : 651 - 660
  • [5] Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+Metastatic Breast Cancer: The DE-REAL Study
    Botticelli, Andrea
    Caputo, Roberta
    Scagnoli, Simone
    Pisegna, Simona
    De Laurentiis, Michelino
    Curigliano, Giuseppe
    Lambertini, Matteo
    Pantano, Francesco
    Palazzo, Antonella
    Paris, Ida
    Vernieri, Claudio
    Tedesco, Beatrice
    Giampaglia, Marianna
    Palleschi, Michela
    Ballatore, Zelmira
    Alesini, Daniele
    D'Auria, Giuliana
    Fabbri, Agnese
    Rossi, Luigi
    Verrazzo, Annarita
    Scafetta, Roberta
    Marinelli, Daniele
    Sposetti, Caterina
    Barberi, Vittoria
    Strigari, Lidia
    Marchetti, Paolo
    Santini, Daniele
    Fabi, Alessandra
    ONCOLOGIST, 2024, 29 (04) : 303 - 310
  • [6] Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study
    Bonotto, Marta
    Basile, Debora
    Gerratana, Lorenzo
    Bartoletti, Michele
    Lisanti, Camilla
    Pelizzari, Giacomo
    Vitale, Maria Grazia
    Fanotto, Valentina
    Poletto, Elena
    Minisini, Alessandro Marco
    Russo, Stefania
    Andreetta, Claudia
    Mansutti, Mauro
    Fasola, Gianpiero
    Puglisi, Fabio
    FUTURE ONCOLOGY, 2020, 16 (27) : 2059 - 2073
  • [7] Real-World Data on Apatinib Efficacy-Results of a Retrospective Study in Metastatic Breast Cancer Patients Pretreated With Multiline Treatment
    Liu, Zhaoyun
    Shan, Jing
    Yu, Qian
    Wang, Xinzhao
    Song, Xiang
    Wang, Fukai
    Li, Chao
    Yu, Zhiyong
    Yu, Jinming
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] Real-world evaluation of the efficacy of immune checkpoint inhibitors in the treatment of metastatic breast cancer
    Qian, Xiaoyan
    Tao, Yunxia
    Chen, Haizhu
    Li, Xin
    Wang, Yaqin
    Xu, Xiaoming
    Li, Shuo
    Chen, Haoyu
    Cang, Shundong
    Liu, Yang
    ONCOLOGY LETTERS, 2025, 29 (01)
  • [9] Real-world experience of abemaciclib for adjuvant and metastatic breast cancer
    Drowne, Taylor
    Armgardt, Emily
    Svoboda, Alison
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2025, 31 (01) : 141 - 146
  • [10] Real-world pharmacokinetics and pharmacodynamics of everolimus in metastatic breast cancer
    Masahide Fukudo
    Kei Ishibashi
    Masahiro Kitada
    Investigational New Drugs, 2021, 39 : 1707 - 1715